NUVB•benzinga•
Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval
Summary
FDA approves Ibtrozi for ROS1+ non-small cell lung cancer based on data from over 300 patients in two pivotal trials showing high response rates.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 11, 2025 by benzinga